Methyl iodide-d3
Product Description
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
Categories
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
More Products from CLEARSYNTH LABS LIMITED (46)
-
Product Rac-Hydroxy Ezetimibe D4
Labeled Ezetimibe, intended for use as an internal standard for the quantification of Ezetimibe by GC- or LC-mass spectrometry. -
Product 4-Hydroxy Atorvastatin D5 Disodium Salt
A labeled metabolite of Atorvastatin,;Labeled Atorvastatin, intended for use as an internal standard for the quantification of Atorvastatin by GC- or LC-mass spectrometry. -
Product Clomiphene Citrate D5
Labelled Clomiphene. Synthetic estrogen agonist-antagonist. Gonad-stimulating principle.;Labeled Clomiphene, intended for use as an internal standard for the quantification of Clomiphene by GC- or LC-mass spectrometry. -
Product Sulfacetamide Sodium
An antibiotic that blocks synthesis of dihydrofolic acid by inhibiting the enzyme dihydropteroate synthase -
Product Deutetrabenazine
Deutetrabenazine is a first-in-class, orally bioavailable deuterated vesicular monoamine transporter 2 (VMAT2) inhibitor approved for the treatment of chorea associated with Huntington’s disease and tardive dyskinesia. -
Product Methyl boronic-d3
Methylboronic Acid-d₃ (CD₃B(OH)₂) is a high-purity deuterated organoboron building block widely used in the synthesis of stable isotope-labeled pharmaceuticals, advanced intermediates, and analytical reference standards. It is an essential reagent for Suzuki–Miyaura cross-coupling reactions, enabling the e... -
Product Methyl tosylate-d3
Methyl Tosylate-d₃ (CD₃OTs) is a high-purity deuterated methylating reagent widely used in the synthesis of stable isotope-labeled pharmaceuticals, intermediates, and analytical reference standards. It enables the efficient introduction of a deuterated methyl (–CD₃) group into target molecules, making it a... -
Product Methylamine-d3 HCl
Methylamine-d₃ Hydrochloride serves as a key deuterated building block for introducing a CD₃-labeled methylamine moiety into complex organic molecules. It is extensively used in the preparation of deuterated drug candidates, impurities, and metabolites, including compounds such as: Deucravacitinib-d₃ ... -
Product Elacestrant Dihydro chloride
Elacestrant Dihydrochloride is a high-purity Active Pharmaceutical Ingredient (API) and oral Selective Estrogen Receptor Degrader (SERD). It selectively targets and degrades estrogen receptor-alpha ($\text{ER}\alpha$), offering a targeted oncological treatment for postmenopausal women and adult men with&nb... -
Product Elacestrant Impurity 3
High-purity Elacestrant Impurity 3 is a key chemical intermediate and structural analogue involved in the synthesis of Elacestrant. It serves as a vital building block for active pharmaceutical ingredient (API) manufacturing and as an analytical reference standard for impurity profiling, method... -
Product N-Ethyl-2-(4-formylphenyl)acetamide
N-Ethyl-2-(4-formylphenyl)acetamide is an essential organic intermediate and structural fragment used in the multi-step chemical synthesis of Elacestrant. It acts as a key building block during late-stage coupling reactions and serves as a vital analytical reference standard for impurity profiling, method ... -
Product Ruxolitinib Phosphate
Ruxolitinib is an orally active, potent, and selective Janus kinase (JAK1 and JAK2) inhibitor. It is indicated for the treatment of myelofibrosis, polycythemia vera, graft-versus-host disease (GvHD), and atopic dermatitis/vitiligo (topical formulation). Manufactured under strict GMP guidelines for use in p...
CLEARSYNTH LABS LIMITED resources (1)
-
Video Clearsynth Intro Video
Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.